Marc Weber
Research Subjects
Research Interests
Marc Weber has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Luis Serrano
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology
8 shared publications - Maria Lluch-Senar
Pulmobiotics, Dr Aiguader 88, Barcelona, Spain
6 shared publications - Javier Buceta
Institute for Integrative Systems Biology, UV-CSIC, Valencia, Spain
4 shared publications - Carolina Gallo
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
3 shared publications Eva Yus
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
3 shared publications- Raul Burgos
Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
3 shared publications
Latest Publications
- Open Access
A Robust Cell-Free RNA Approach for the Early Detection of Colorectal Cancer
Colorectal cancer (CRC) screening remains limited by patient adherence and sub-optimal sensitivity for early-stage disease. While liquid biopsy has revolutionized cancer diagnostics, cfDNA-based methods often struggle with early-stage detection due to low analyte levels. Here, we present a robust cell-free RNA (cfRNA) platform for the early detection of CRC. Using a retrospective cohort of 255 healthy controls and 250 CRC patients, we implemented an optimized workflow featuring a RUVg-based normalization strategy to remove platelet-driven transcriptomic noise. We identified differentially expressed genes enriched in key CRC-associated biological pathways, including inflammation, EMT, and metabolic dysregulation. An XGBoost classifier trained on these features achieved a mean AUC of 0.92 in cross-validation and 0.89 in a validation cohort, demonstrating 67% sensitivity at 90% specificity. Notably, our platform showed particular efficacy in identifying early stage cancer (stage I and II), achieving 73.7% sensitivity at 90% specificity. These findings suggest that cfRNA profiling offers a powerful, non-invasive orthogonal approach to CRC screening, capable of overcoming the sensitivity limitations of DNA-based assays in early-stage disease.
Open AccessA Robust Cell-Free RNA Approach for the Early Detection of Colorectal Cancer
Colorectal cancer (CRC) screening remains limited by patient adherence and sub-optimal sensitivity for early-stage disease. While liquid biopsy has revolutionized cancer diagnostics, cfDNA-based methods often struggle with early-stage detection due to low analyte levels. Here, we present a robust cell-free RNA (cfRNA) platform for the early detection of CRC. Using a retrospective cohort of 255 healthy controls and 250 CRC patients, we implemented an optimized workflow featuring a RUVg-based normalization strategy to remove platelet-driven transcriptomic noise. We identified differentially expressed genes enriched in key CRC-associated biological pathways, including inflammation, EMT, and metabolic dysregulation. An XGBoost classifier trained on these features achieved a mean AUC of 0.92 in cross-validation and 0.89 in a validation cohort, demonstrating 67% sensitivity at 90% specificity. Notably, our platform showed particular efficacy in identifying early stage cancer (stage I and II), achieving 73.7% sensitivity at 90% specificity. These findings suggest that cfRNA profiling offers a powerful, non-invasive orthogonal approach to CRC screening, capable of overcoming the sensitivity limitations of DNA-based assays in early-stage disease.
- Open Access
Systematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which compromises reproducibility and comparability across studies. There is a need for a systematic evaluation of existing cfRNA-Seq workflows to understand the drivers of technical variability. Here, we address this gap by performing a comprehensive cross-study analysis of 2,166 cfRNA-Seq samples from 15 published studies and an in-house generated dataset, applying a uniform bioinformatics pipeline to enable a controlled comparison of experimental workflows. Our analysis reveals that the donor phenotype typically explains a negligible fraction of the transcriptomic variation, whose main determinants are technical – principally protocol choice, genomic DNA contamination levels and library diversity. Remarkably, this technical noise is so profound that variation within plasma cfRNA samples exceeds that found across a wide range of human tissues. Finally, we demonstrate that critical pre-analytical factors are often confounded with patient phenotypes, jeopardizing the validity of biomarker discovery efforts. Our work serves as a comprehensive benchmark of current cfRNA-Seq methodologies and provides evidence-based guidelines to improve experimental design. By highlighting the dominance of controllable technical factors, we offer a path towards more robust and reproducible cfRNA research.
Open AccessSystematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which compromises reproducibility and comparability across studies. There is a need for a systematic evaluation of existing cfRNA-Seq workflows to understand the drivers of technical variability. Here, we address this gap by performing a comprehensive cross-study analysis of 2,166 cfRNA-Seq samples from 15 published studies and an in-house generated dataset, applying a uniform bioinformatics pipeline to enable a controlled comparison of experimental workflows. Our analysis reveals that the donor phenotype typically explains a negligible fraction of the transcriptomic variation, whose main determinants are technical – principally protocol choice, genomic DNA contamination levels and library diversity. Remarkably, this technical noise is so profound that variation within plasma cfRNA samples exceeds that found across a wide range of human tissues. Finally, we demonstrate that critical pre-analytical factors are often confounded with patient phenotypes, jeopardizing the validity of biomarker discovery efforts. Our work serves as a comprehensive benchmark of current cfRNA-Seq methodologies and provides evidence-based guidelines to improve experimental design. By highlighting the dominance of controllable technical factors, we offer a path towards more robust and reproducible cfRNA research.
- Open Access
- 29 August 2023
- Published by Springer Nature in Molecular Systems Biology
- Vol. 19 (10) , e11301
Comprehensive quantitative modeling of translation efficiency in a genome‐reduced bacterium
Translation efficiency has been mainly studied by ribosome profiling, which only provides an incomplete picture of translation kinetics. Here, we integrated the absolute quantifications of tRNAs, mRNAs, RNA half‐lives, proteins, and protein half‐lives with ribosome densities and derived the initiation and elongation rates for 475 genes (67% of all genes), 73 with high precision, in the bacterium Mycoplasma pneumoniae ( Mpn ). We found that, although the initiation rate varied over 160‐fold among genes, most of the known factors had little impact on translation efficiency. Local codon elongation rates could not be fully explained by the adaptation to tRNA abundances, which varied over 100‐fold among tRNA isoacceptors. We provide a comprehensive quantitative view of translation efficiency, which suggests the existence of unidentified mechanisms of translational regulation in Mpn .
- 29 August 2023
- Published by Springer Nature in Molecular Systems Biology
- Vol. 19 (10) , e11301
Open AccessComprehensive quantitative modeling of translation efficiency in a genome‐reduced bacterium
Translation efficiency has been mainly studied by ribosome profiling, which only provides an incomplete picture of translation kinetics. Here, we integrated the absolute quantifications of tRNAs, mRNAs, RNA half‐lives, proteins, and protein half‐lives with ribosome densities and derived the initiation and elongation rates for 475 genes (67% of all genes), 73 with high precision, in the bacterium Mycoplasma pneumoniae ( Mpn ). We found that, although the initiation rate varied over 160‐fold among genes, most of the known factors had little impact on translation efficiency. Local codon elongation rates could not be fully explained by the adaptation to tRNA abundances, which varied over 100‐fold among tRNA isoacceptors. We provide a comprehensive quantitative view of translation efficiency, which suggests the existence of unidentified mechanisms of translational regulation in Mpn .
- Open Access
Evolutionary conservation of A/T-ending codons reflects co-regulation of expression and complex formation
Background In a wide variety of organisms, synonymous codons are used with different frequencies, a phenomenon known as codon bias that plays an important role in determining expression levels. However, the importance of codon bias to facilitate the simultaneous turnover of thousands of protein-coding transcripts to bring about phenotypic changes in cellular programs such as development, has not yet been investigated in detail. Results Here, we discover that genes with A/T-ending codon preferences are expressed coordinately and display a high codon conservation in mammals. This feature is not observed in genes enriched in G/C-ending codons. A paradigmatic case of this phenomenon is KRAS, from the RAS family, an A/T-rich gene with a high codon conservation (95%) in comparison to HRAS (76%). Also, we find that genes with similar codon composition are more likely to be part of the same protein complex, and that genes with A/T-ending codons are more prone to form protein complexes than those rich in G/C. The codon preferences of genes with A/T-ending codons are conserved among vertebrates. We propose that codon conservation, a feature of expression-coordinated transcripts, is linked to the high expression variation and coordination of tRNA isoacceptors reading A/T-ending codons. Conclusions Our data indicate that cells exploit A/T-ending codons to generate coordinated, fine-tuned changes of protein-coding transcripts. We suggest that this orchestration contributes to tissue-specific and ontogenetic-specific expression, which can facilitate, for instance, timely protein complex formation.
Open AccessEvolutionary conservation of A/T-ending codons reflects co-regulation of expression and complex formation
Background In a wide variety of organisms, synonymous codons are used with different frequencies, a phenomenon known as codon bias that plays an important role in determining expression levels. However, the importance of codon bias to facilitate the simultaneous turnover of thousands of protein-coding transcripts to bring about phenotypic changes in cellular programs such as development, has not yet been investigated in detail. Results Here, we discover that genes with A/T-ending codon preferences are expressed coordinately and display a high codon conservation in mammals. This feature is not observed in genes enriched in G/C-ending codons. A paradigmatic case of this phenomenon is KRAS, from the RAS family, an A/T-rich gene with a high codon conservation (95%) in comparison to HRAS (76%). Also, we find that genes with similar codon composition are more likely to be part of the same protein complex, and that genes with A/T-ending codons are more prone to form protein complexes than those rich in G/C. The codon preferences of genes with A/T-ending codons are conserved among vertebrates. We propose that codon conservation, a feature of expression-coordinated transcripts, is linked to the high expression variation and coordination of tRNA isoacceptors reading A/T-ending codons. Conclusions Our data indicate that cells exploit A/T-ending codons to generate coordinated, fine-tuned changes of protein-coding transcripts. We suggest that this orchestration contributes to tissue-specific and ontogenetic-specific expression, which can facilitate, for instance, timely protein complex formation.
- Open Access
- 1 October 2021
- Published by Springer Nature in Molecular Systems Biology
- Vol. 17 (10) , e10145
Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
Bacteria present a promising delivery system for treating human diseases. Here, we engineered the genome‐reduced human lung pathogen Mycoplasma pneumoniae as a live biotherapeutic to treat biofilm‐associated bacterial infections. This strain has a unique genetic code, which hinders gene transfer to most other bacterial genera, and it lacks a cell wall, which allows it to express proteins that target peptidoglycans of pathogenic bacteria. We first determined that removal of the pathogenic factors fully attenuated the chassis strain in vivo . We then designed synthetic promoters and identified an endogenous peptide signal sequence that, when fused to heterologous proteins, promotes efficient secretion. Based on this, we equipped the chassis strain with a genetic platform designed to secrete antibiofilm and bactericidal enzymes, resulting in a strain capable of dissolving Staphylococcus aureus biofilms preformed on catheters in vitro , ex vivo , and in vivo . To our knowledge, this is the first engineered genome‐reduced bacterium that can fight against clinically relevant biofilm‐associated bacterial infections.
- 1 October 2021
- Published by Springer Nature in Molecular Systems Biology
- Vol. 17 (10) , e10145
Open AccessEngineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
Bacteria present a promising delivery system for treating human diseases. Here, we engineered the genome‐reduced human lung pathogen Mycoplasma pneumoniae as a live biotherapeutic to treat biofilm‐associated bacterial infections. This strain has a unique genetic code, which hinders gene transfer to most other bacterial genera, and it lacks a cell wall, which allows it to express proteins that target peptidoglycans of pathogenic bacteria. We first determined that removal of the pathogenic factors fully attenuated the chassis strain in vivo . We then designed synthetic promoters and identified an endogenous peptide signal sequence that, when fused to heterologous proteins, promotes efficient secretion. Based on this, we equipped the chassis strain with a genetic platform designed to secrete antibiofilm and bactericidal enzymes, resulting in a strain capable of dissolving Staphylococcus aureus biofilms preformed on catheters in vitro , ex vivo , and in vivo . To our knowledge, this is the first engineered genome‐reduced bacterium that can fight against clinically relevant biofilm‐associated bacterial infections.
- Open Access
Widespread ribosome stalling in a genome-reduced bacterium and the need for translational quality control
- Open Access
- 1 December 2020
- Published by Springer Nature in Molecular Systems Biology
- Vol. 16 (12) , e9530
Protein quality control and regulated proteolysis in the genome‐reduced organism Mycoplasma pneumoniae
Protein degradation is a crucial cellular process in all‐living systems. Here, using Mycoplasma pneumoniae as a model organism, we defined the minimal protein degradation machinery required to maintain proteome homeostasis. Then, we conditionally depleted the two essential ATP‐dependent proteases. Whereas depletion of Lon results in increased protein aggregation and decreased heat tolerance, FtsH depletion induces cell membrane damage, suggesting a role in quality control of membrane proteins. An integrative comparative study combining shotgun proteomics and RNA‐seq revealed 62 and 34 candidate substrates, respectively. Cellular localization of substrates and epistasis studies supports separate functions for Lon and FtsH. Protein half‐life measurements also suggest a role for Lon‐modulated protein decay. Lon plays a key role in protein quality control, degrading misfolded proteins and those not assembled into functional complexes. We propose that regulating complex assembly and degradation of isolated proteins is a mechanism that coordinates important cellular processes like cell division. Finally, by considering the entire set of proteases and chaperones, we provide a fully integrated view of how a minimal cell regulates protein folding and degradation.
- 1 December 2020
- Published by Springer Nature in Molecular Systems Biology
- Vol. 16 (12) , e9530
Open AccessProtein quality control and regulated proteolysis in the genome‐reduced organism Mycoplasma pneumoniae
Protein degradation is a crucial cellular process in all‐living systems. Here, using Mycoplasma pneumoniae as a model organism, we defined the minimal protein degradation machinery required to maintain proteome homeostasis. Then, we conditionally depleted the two essential ATP‐dependent proteases. Whereas depletion of Lon results in increased protein aggregation and decreased heat tolerance, FtsH depletion induces cell membrane damage, suggesting a role in quality control of membrane proteins. An integrative comparative study combining shotgun proteomics and RNA‐seq revealed 62 and 34 candidate substrates, respectively. Cellular localization of substrates and epistasis studies supports separate functions for Lon and FtsH. Protein half‐life measurements also suggest a role for Lon‐modulated protein decay. Lon plays a key role in protein quality control, degrading misfolded proteins and those not assembled into functional complexes. We propose that regulating complex assembly and degradation of isolated proteins is a mechanism that coordinates important cellular processes like cell division. Finally, by considering the entire set of proteases and chaperones, we provide a fully integrated view of how a minimal cell regulates protein folding and degradation.
- 16 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (48) , 30848-30856
Mutation bias within oncogene families is related to proliferation-specific codon usage
Significance: In light of the genetic code, combinations of three nucleotides which are known as synonymous codons, can give rise to the same amino acid. Despite the homology at the protein level, these different codons are recognized distinctly by the translational machinery. The unequal use of synonymous codons influences protein expression. Surprisingly, we find that the coding sequences of KRAS and other frequently mutated cancer genes are adapted to be efficiently translated in proliferating cells in comparison to their family counterparts. Our work contributes to the unsolved question of why in tumors some members of cancer gene families show a higher mutation rate than their family counterparts. Thus, our results elucidate the relationship between tRNA expression, codon usage, and oncogenicity.
- 16 November 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (48) , 30848-30856
Mutation bias within oncogene families is related to proliferation-specific codon usage
Significance: In light of the genetic code, combinations of three nucleotides which are known as synonymous codons, can give rise to the same amino acid. Despite the homology at the protein level, these different codons are recognized distinctly by the translational machinery. The unequal use of synonymous codons influences protein expression. Surprisingly, we find that the coding sequences of KRAS and other frequently mutated cancer genes are adapted to be efficiently translated in proliferating cells in comparison to their family counterparts. Our work contributes to the unsolved question of why in tumors some members of cancer gene families show a higher mutation rate than their family counterparts. Thus, our results elucidate the relationship between tRNA expression, codon usage, and oncogenicity.
- Open Access
- 1 May 2020
- Published by Springer Nature in Molecular Systems Biology
- Vol. 16 (5) , e9208
Impact of C‐terminal amino acid composition on protein expression in bacteria
The C‐terminal sequence of a protein is involved in processes such as efficiency of translation termination and protein degradation. However, the general relationship between features of this C‐terminal sequence and levels of protein expression remains unknown. Here, we identified C‐terminal amino acid biases that are ubiquitous across the bacterial taxonomy (1,582 genomes). We showed that the frequency is higher for positively charged amino acids (lysine, arginine), while hydrophobic amino acids and threonine are lower. We then studied the impact of C‐terminal composition on protein levels in a library of Mycoplasma pneumoniae mutants, covering all possible combinations of the two last codons. We found that charged and polar residues, in particular lysine, led to higher expression, while hydrophobic and aromatic residues led to lower expression, with a difference in protein levels up to fourfold. We further showed that modulation of protein degradation rate could be one of the main mechanisms driving these differences. Our results demonstrate that the identity of the last amino acids has a strong influence on protein expression levels.
- 1 May 2020
- Published by Springer Nature in Molecular Systems Biology
- Vol. 16 (5) , e9208
Open AccessImpact of C‐terminal amino acid composition on protein expression in bacteria
The C‐terminal sequence of a protein is involved in processes such as efficiency of translation termination and protein degradation. However, the general relationship between features of this C‐terminal sequence and levels of protein expression remains unknown. Here, we identified C‐terminal amino acid biases that are ubiquitous across the bacterial taxonomy (1,582 genomes). We showed that the frequency is higher for positively charged amino acids (lysine, arginine), while hydrophobic amino acids and threonine are lower. We then studied the impact of C‐terminal composition on protein levels in a library of Mycoplasma pneumoniae mutants, covering all possible combinations of the two last codons. We found that charged and polar residues, in particular lysine, led to higher expression, while hydrophobic and aromatic residues led to lower expression, with a difference in protein levels up to fourfold. We further showed that modulation of protein degradation rate could be one of the main mechanisms driving these differences. Our results demonstrate that the identity of the last amino acids has a strong influence on protein expression levels.
- Open Access
Impact of C-terminal amino acid composition on protein expression in bacteria
The C-terminal sequence of a protein is involved in processes such as efficiency of translation termination and protein degradation. However, the general relationship between features of this C-terminal sequence and levels of protein expression remains unknown. Here, we identified C-terminal amino acid biases that are ubiquitous across the bacterial taxonomy (1582 genomes). We showed that the frequency is higher for positively charged amino acids (lysine, arginine) while hydrophobic amino acids and threonine are lower. In highly abundant proteins, the C-terminal residue is more conserved. We then studied the impact of C-terminal composition on protein levels in a library of M. pneumoniae mutants, covering all possible combinations of the two last codons. We found that charged and polar residues, in particular lysine, led to higher expression, while hydrophobic and aromatic residues led to lower expression, with a difference in protein levels up to 4-fold. Our results demonstrate that the identity of the last amino acids has a strong influence on protein expression levels and is under selective pressure in highly expressed proteins.
Open AccessImpact of C-terminal amino acid composition on protein expression in bacteria
The C-terminal sequence of a protein is involved in processes such as efficiency of translation termination and protein degradation. However, the general relationship between features of this C-terminal sequence and levels of protein expression remains unknown. Here, we identified C-terminal amino acid biases that are ubiquitous across the bacterial taxonomy (1582 genomes). We showed that the frequency is higher for positively charged amino acids (lysine, arginine) while hydrophobic amino acids and threonine are lower. In highly abundant proteins, the C-terminal residue is more conserved. We then studied the impact of C-terminal composition on protein levels in a library of M. pneumoniae mutants, covering all possible combinations of the two last codons. We found that charged and polar residues, in particular lysine, led to higher expression, while hydrophobic and aromatic residues led to lower expression, with a difference in protein levels up to 4-fold. Our results demonstrate that the identity of the last amino acids has a strong influence on protein expression levels and is under selective pressure in highly expressed proteins.